|
| Press Releases |
|
 |
|
| Friday, August 29, 2025 |
|
|
Fosun's Bold Innovation & Globalization Drive Valuation Upside |
| Fosun International (HKEX: 00656) announced its 2025 interim results, with total revenue reaching RMB87.28 billion, industrial operation profit amounting to RMB3.15 billion, and profit attributable to owners of the parent reaching RMB661.2 million. more info >> |
|
|
復星創新和全球化多點破局 估值打開想像空間 |
| 復星國際（HKEX: 00656）發佈2025年上半年業績，總收入達人民幣872.8億元，產業運營利潤達人民幣31.5億元，歸母淨利潤達人民幣6.6億元。 more info >> |
|
| Tuesday, April 1, 2025 |
|
|
Fosun's Stable Fundamentals Support its Clear Growth Path |
| Fosun International (HKEX: 0656), which is committed to advancing its core business-focused and business streamlining strategy, announced its 2024 annual results on 30 March. more info >> |
|
|
復星年度業績基本面穩健，未來增長路徑清晰 |
| 持續推進「瘦身健體，聚焦主業」的復星國際，3月30日公佈2024年全年業績。 more info >> |
|
| Monday, March 31, 2025 |
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss |
| On 30 March, Fosun International (00656) announced its 2024 annual results, reporting a total revenue of RMB192.14 billion. The Group's four core subsidiaries - Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group ("FTG") - generated a total revenue of RMB134.65 billion, accounting for 70.1% of the Group's total revenue. more info >> |
|
|
复星一次性非现金账面损失不影响业务稳健发展 |
| 3月30日，复星国际（00656）公布2024年度业绩，总收入达到人民币1921.4亿元，其中，四大核心子公司豫园股份、复星医药、复星葡萄牙保险和复星旅文，总收入达到人民币1346.5亿元，占集团总收入的比重达到70.1%。归属于母公司股东之亏损为人民币43.5亿元，主要是受累阿里巴巴集团低价回购菜鸟致股份账面值大减。 more info >> |
|
|
復星一次性非現金賬面損失不影響業務穩健發展 |
| 3月30日，復星國際（00656）公佈2024年度業績，總收入達到人民幣1921.4億元，其中，四大核心子公司豫園股份、復星醫藥、復星葡萄牙保險和復星旅文，總收入達到人民幣1346.5億元，佔集團總收入的比重達到70.1%。歸屬於母公司股東之虧損為人民幣43.5億元，主要是受累阿里巴巴集團低價回購菜鳥致股份賬面值大減。 more info >> |
|
| Friday, December 13, 2024 |
|
|
Fosun Bolsters Core Business with Two Key Asset Privatizations |
| On the evening of 10 December, Fosun Tourism Group (FTG) announced on the Hong Kong Stock Exchange its plan to repurchase shares at a price of HK$7.8 per share. This price represents a 111% premium over the closing price of the day before the last trading day. more info >> |
|
|
连续私有化两家核心企业 复星深化主业布局 |
| 12月10日晚间，复星旅文在港交所发布公告，宣布拟以每股7.8港元的价格回购股份。该价格较最后交易日前一天的收盘价溢价111%。本次私有化将复星旅文的整体估值提升至105亿港元。消息一出，引发广泛关注。 more info >> |
|
|
連續私有化兩家核心企業 復星深化主業佈局 |
| 12月10日晚間，復星旅文在港交所發佈公告，宣佈擬以每股7.8港元的價格回購股份。該價格較最後交易日前一天的收盤價溢價111%。本次私有化將復星旅文的整體估值提升至105億港元。消息一出，引發廣泛關注。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OBIファーマとTegMine Therapeutics、糖鎖標的ADCに関する独占的グローバルライセンス契約を締結
Jan 12, 2026 21:00: JST
|
|
|
浩鼎與 TegMine Therapeutics簽訂醣標靶ADC 全球商業授權合約
Jan 12, 2026 20:00 HKT/SGT
|
|
|
浩鼎与 TegMine Therapeutics 签订醣靶标 ADC 全球商业授权合约
Jan 12, 2026 20:00 HKT/SGT
|
|
|
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Jan 12, 2026 20:00 HKT/SGT
|
|
|
查理控股（OTCQB:CHUC）與IKE科技簽署協議，將推出革命性年齡驗證電子煙產品以解決FDA對青少年接觸的擔憂
Jan 12, 2026 19:00 HKT/SGT
|
|
|
查理控股公司（OTCQB:CHUC）与IKE科技签署协议，将推出革命性年龄验证电子烟产品以解决FDA对青少年获取渠道的担忧
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Toys & Games Fair, Baby Products Fair and Stationery & School Supplies Fair open today
Jan 12, 2026 18:26 HKT/SGT
|
|
|
Argentine Football Association (AFA) arbeitet mit Verofax zusammen, um Fans KI-gestützte Erlebnisse zu bieten
Jan 12, 2026 16:00 HKT/SGT
|
|
|
聯想之星與君聯資本所投企業精鋒醫療在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
联想之星与君联资本所投企业精锋医疗在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
Mazda Unveils MAZDA CX-6e New Battery EV in World Premiere
Jan 12, 2026 13:10 JST
|
|
|
Argentine Football Association (AFA) se asocia con Verofax para ofrecer experiencias de IA a los aficionados
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association (AFA), Verofax와 협력 팬을 위한 AI 경험 제공
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association（AFA）攜手 Verofax 為球迷提供 AI 互動體驗
Jan 12, 2026 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
